The Best AI Tools for Science (2026)

AI tools for scientific literature are multiplying quickly, but they are not interchangeable. Some are built to screen hundreds of papers at once, some to give a fast read on whether a claim is supported, and others to help you work through one difficult paper in detail. Picking the right one depends less on which tool is "best" and more on what you are actually trying to do.

Below are four of the strongest tools available in 2026, with what each does well and where it falls short, followed by a note on where Clarisyn fits in.

Elicit

Elicit is one of the more mature tools for structured literature review, and its real strength is data extraction. You tell it which fields matter, sample size, intervention, outcome, effect measure, and it pulls those details into a structured table across a large set of papers.

That turns out to be exactly what systematic and scoping reviews need, where the hard part isn't finding papers so much as screening them consistently and turning what's inside them into something you can actually compare. Elicit searches over 138 million papers and has dedicated workflows for both screening and extraction.

Its main limitation is that it's built for breadth, not depth in any one field. It works across every discipline rather than around biomedical evidence specifically, and the more capable screening and extraction features live in the paid plans.

Best for: systematic reviews, screening, and structured evidence extraction.

Consensus

Consensus is built for a narrower kind of question: which way does the published evidence actually point?

Ask it something yes-or-no and its Consensus Meter reads through the relevant papers and shows how strongly they lean toward yes, no, or maybe. The search behind it covers more than 200 million papers, ranked by relevance along with signals like citation count, recency, and study design.

The thing to keep in mind is what that meter is really showing you. It reflects the papers Consensus retrieved for your specific query, not the whole of the literature. So it's a good way to get an early read on where things seem to stand, but when the answer actually matters, there's no shortcut around looking at study design, effect size, population, and quality yourself.

Best for: quickly checking which way the evidence leans.

Scite

Scite comes at the literature from a different direction. Rather than focusing on what a paper claims, it looks at what everyone who cited it said afterwards.

Its Smart Citations pull the context around each citation and sort it into supporting, contrasting, or just mentioning the original work. Do that across more than 1.6 billion citation statements and you can suddenly see something citation counts never tell you: whether a heavily cited finding has held up in later work or been quietly picked apart.

The catch is that the sorting is automated, and most citations don't fall cleanly into "supports" or "contradicts." So the labels are a useful starting signal rather than the last word, and for anything important it's still worth reading the surrounding context yourself.

Best for: seeing how a finding has held up in later research.

SciSpace

SciSpace made its name helping researchers get through difficult papers. Open one up and you can ask about a method, a figure, a result, or a single confusing passage, and get an explanation tied back to where it came from in the text.

That's still what it does best, especially when the problem isn't finding more papers but making sense of the one in front of you.

It has grown well beyond that since, though. It now searches around 280 million papers and layers on agent workflows for literature review, systematic review, data extraction, and biomedical search, which makes it more of an all-round research workspace than it started out as. Those newer features are less settled than the reading experience, so if getting through a dense paper is your immediate problem, that original strength is still the reason to reach for it.

Best for: reading and understanding complex papers.

Where Clarisyn fits

Most researchers end up using two or three of these together, because each was built for a different stage: discovery, reading, checking, extraction. That is a sensible way to work, but it also means the reasoning ends up split across tools that don't talk to each other.

Clarisyn, the tool we build at R2H, takes a narrower and more deliberate approach. Instead of covering science in general, it is built around the evidence that matters for drug discovery and the life sciences, drawing on more than 200 datasets across peer-reviewed literature, clinical trials, chemical databases, and protein and genetic data. Rather than one model answering in a single pass, several agents work a question independently, and their outputs are cross-checked against each other and against the underlying sources. When the literature disagrees, that disagreement is surfaced rather than smoothed into one clean answer. A researcher stays in the loop throughout, and when a question calls for it, expert review is one step away.

It isn't built to do everything the tools above do, and for many general tasks they remain excellent choices. But if what you need is biomedical evidence you can actually audit, from the conclusion all the way down to the paper it came from, that is the specific problem Clarisyn is built to solve.